A preliminary study to identify correlations between blood glucose levels and cardiorespiratory observations in acute asthma patients receiving nebulised salbutamol. Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
Sequential nebulized salbutamol therapy in patients of acute bronchial asthma and its effect on serum potassium level Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003
High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020
Effect of intravenous hydrocortisone on nocturnal airflow limitation in childhood asthma Source: Eur Respir J 2003; 21: 627-632 Year: 2003
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients Source: Eur Respir J 2001; 17: 863-867 Year: 2001
Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma Source: Eur Respir J 2001; 17: 374-379 Year: 2001
Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Systemic effects of nebulized salbutamol on serum potassium, glucose and CPK-MB levels in children with acute reversible reactive airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
The role of nebulised budesonide in the treatment of acute exacerbations of COPD Source: Eur Respir J 2007; 30: 399-400 Year: 2007
Serum potassium level in patient of bronchial asthma on sequential nebulized salbutamol therapy Source: Eur Respir J 2007; 30: Suppl. 51, 621s Year: 2007
Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol Source: Eur Respir J 2001; 17: 368-373 Year: 2001
Effects of ciclesonide on lung function and cortisol excretion in adolescent asthma patients – a comparative study with budesonide Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006
Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
REVERDIL study: validity of salbutamol in determining COPD reversibility prior to formoterol treatment Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003
FEV1 response to albuterol is not affected by inhaled human insulin (Exubera®) use in subjects with mild-to-moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 840s Year: 2006
Effects of nedocromil and salbutamol on airway reactivity in children with asthma Source: Eur Respir J 2002; 20: 624-629 Year: 2002